RCC

Interventional oncology for renal cell carcinoma

Renal cell carcinoma (RCC) accounts for approximately 3% of all adult cancers with an estimated 12.1 new cases per year for 100,000 of population in the western world. The incidence rate of sporadic RCC has increased in the last two decades, mainly due to the increased use of cross-sectional imaging but also due to obesity […]

Gus Rottenberg, Renganaden Pyneeandee, Dr Miltiadis Krokidis

University of Cambridge, Cambridge University Hospitals NHS Trust

Read Article

Image guided ablation of renal cell carcinoma

Renal cell carcinoma (RCC) is the seventh most common cancer in the UK, accounting for 3% of all new cases. The increased incidence in the population is largely due to the greater usage of imaging to investigate patients and also partly due to true increased incidence as a result of smoking, obesity and hypertension.

Dr Atif Khan, Professor Dr Tze Min Wah

Leeds Teaching Hospitals Trust

Read Article

Percutaneous thermal ablation for small renal masses

Renal cell carcinoma (RCC) is among the ten most common tumours in men and women. Evolution of imaging modalities, accompanied by extensive screening and imaging surveillance for other diseases, has led to an increased number of small renal tumours being detected incidentally at earlier stages. More than 80% of small renal masses (SRM) are proven […]

Dr Konstantinos Katsanos, Dr Shahzad Ilyas, Professor Andreas Adam

Guy's and St Thomas' Hospital NHS Foundation Trust

Read Article

Abdominal ultrasound imaging – don’t overlook the kidneys

Primary renal neoplasm is the eighth most common cancer in the UK, with renal cell carcinomas (RCCs) responsible for approximately 86% of all cases. The majority of RCCs are clinically occult and are discovered incidentally on radiographic studies. The classic triad presentation of flank pain, haematuria and palpable mass are only reported in 10% of […]

Dr K Choi, Dr J Taylor

Royal Blackburn Hospital

Read Article

Stay up to date with
RAD Magazine

Sign up for our newsletter.

We care about your data. Read our privacy policy.